Altesa BioSciences, Inc. — Form D/A
Altesa BioSciences, Inc. of COLLEGE PARK, GA, a company, filed a Form D amendment with the SEC on 2023-07-07. The offering totals $35.0M, of which $35.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-07-07
- Form: D/A
- Accession: 0001960618-23-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $35.0M
- Investors: 18
- Date of first sale: 2022-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469770
Issuer
- Name: Altesa BioSciences, Inc.
- CIK: 0001960618
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1930 HARVARD AVENUE, COLLEGE PARK, GA, 30337
- Phone: 703-795-4274
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Brett Giroir | Director | College Park, GA |
| Ittai Harel | Director | College Park, GA |
| Seth Rudnick | Director | DURHAM, NC |
| Moncef Slaoui | Director | College Park, GA |
| NICHOLAS WILLIAMS | Director | LONDON, X0 |
| John Clerici | Executive Officer | College Park, GA |
| Brett Giroir | Executive Officer | College Park, GA |
| Brett Giroir | Promoter | College Park, GA |
| John Clerici | Promoter | College Park, GA |
| Jon Edwards | Director | College Park, GA |
| Andrew Drechsler | Executive Officer | College Park, GA |
Other filings by this issuer (2)
More